BridgeMD
New treatment option for Carcinoma, Squamous Cell
Official title A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.
ClinicalTrials.gov ID: NCT02743832
What this study is testing
- What it's testing
- The purpose of this study is to determine whether cervical lymph node dissection is necessarily performed in the presence of early-stage oral squamous cell carcinoma.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70
You may be able to join if
- Han race;
- Oral squamous cell carcinoma is confirmed by pathology;
- The section of oral squamous cell carcinoma including primary two-thirds prior to the tongue, buccal mucosa， gingiva， mouth floor， hard palate mucosa;
- The primary lesion is no more than 4cm;
- Do not find cervical lymph node metastases and distant metastasis in the clinical examination including physical examination and MRI;
You likely can't join if
- Do not meet the inclusion criteria;
- The primary lesion is more than 4cm or invade adjacent tissues;
- Do not review on schedule;
- Patients receive not only surgical procedures, but other antineoplastic treatment;
- There are serious adverse events after operation;
- Patients quit the study voluntarily;
See the full eligibility criteria
- Han race;
- Oral squamous cell carcinoma is confirmed by pathology;
- The section of oral squamous cell carcinoma including primary two-thirds prior to the tongue, buccal mucosa， gingiva， mouth floor， hard palate mucosa;
- The primary lesion is no more than 4cm;
- Do not find cervical lymph node metastases and distant metastasis in the clinical examination including physical examination and MRI;
- Patients and families agree to participate in the study;
- Patients do not have cognitive disorders.
- Do not meet the inclusion criteria;
- The primary lesion is more than 4cm or invade adjacent tissues;
- Do not review on schedule;
- Patients receive not only surgical procedures, but other antineoplastic treatment;
- There are serious adverse events after operation;
- Patients quit the study voluntarily;
- Patients quit the study because of physical condition.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.